C1-inhibitor reduces hepatic leukocyte-endothelial interaction and the expression of VCAM-1 in LPS-induced sepsis in the rat

Microvascular Research

Volumn 67, Issue 2, 2004, Pages 182-191

  Croner, Roland S ^a,b   Lehmann, Thorsten G ^a   Fallsehr, Christina ^a   Herfarth, Christian ^a   Klar, Ernst ^a   Kirschfink, Michael ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

Adhesion molecules; C1 inhibitor; Complement system; Inflammation; Liver; Sepsis

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; BERINERT; COMPLEMENT COMPONENT C1S INHIBITOR; COMPLEMENT COMPONENT C3A; MESSENGER RNA; RINGER SOLUTION; SODIUM CHLORIDE; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL WALL; CELL INTERACTION; CONTROLLED STUDY; DRUG RESEARCH; ERYTHROCYTE; ESCHERICHIA COLI; GENE EXPRESSION; LEUKOCYTE; LEUKOCYTE ADHERENCE; LIVER CELL; LIVER SINUSOID; MALE; MICROCIRCULATION; MICROSCOPY; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RAT; SALT INTAKE; SEPSIS; VASCULAR ENDOTHELIUM; VENULE;

ANIMALS; BLOOD FLOW VELOCITY; CELL ADHESION; COMPLEMENT ACTIVATION; COMPLEMENT C1 INACTIVATOR PROTEINS; COMPLEMENT C1 INHIBITOR PROTEIN; COMPLEMENT C3A; DRUG EVALUATION, PRECLINICAL; ENDOTHELIUM, VASCULAR; GENE EXPRESSION REGULATION; HEMODYNAMIC PROCESSES; LEUKOCYTES; LIPOPOLYSACCHARIDES; LIVER; MALE; MICROCIRCULATION; RANDOM ALLOCATION; RATS; RATS, WISTAR; SEPSIS; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR CELL ADHESION MOLECULE-1;

ANIMALIA; ESCHERICHIA COLI; MINK ENTERITIS VIRUS;

EID: 1542358725     PISSN: 00262862     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mvr.2003.09.009     Document Type: Article

References (57)

1. Banafsche R., Gunther L., Nefflen J.U.et al. NF-kappa B antisense oligonucleotides reduce leukocyte-endothelial interaction in hepatic ischemia-reperfusion. Transplant Proc. 33(7-8):2001;3726-3727.
2. Bengtson A., Heideman M. Anaphylatoxin formation in sepsis. Arch. Surg. 123(5):1988;645-649.
3. Bork K., Witzke G. Long-term prophylaxis with C1-inhibitor (C1-INH) concentrate in patients with recurrent angioedema caused by hereditary and acquired C1-inhibitor deficiency. J. Allergy Clin. Immunol. 83(3):1989;677-682.
4. Buerke M., Prufer D., Dahm M.et al. Blocking of classical complement pathway inhibits endothelial adhesion molecule expression and preserves ischemic myocardium from reperfusion injury. J. Pharmacol. Exp. Ther. 286(1):1998;429-438.
5. Carlos T.M., Schwartz B.R., Kovach N.L.et al. Vascular cell adhesion molecule-1 mediates lymphocyte adherence to cytokine-activated cultured human endothelial cells. Blood. 76(5):1990;965-970.
6. Collard C.D., Agah A., Reenstra W.et al. Endothelial nuclear factor-kappa B translocation and vascular cell adhesion molecule-1 induction by complement: inhibition with anti-human C5 therapy or cGMP analogues. Arterioscler., Thromb., Vasc. Biol. 19(11):1999;2623-2629.
7. Foreman K.E., Vaporciyan A.A., Bonish B.K.et al. C5a-induced expression of P-selectin in endothelial cells. J. Clin. Invest. 94(3):1994;147-155.
8. Hack C.E., Ogilvie A.C., Eisele B.et al. C1-inhibitor substitution therapy in septic shock and in the vascular leak syndrome induced by high doses of interleukin-2. Intensive Care Med. 19(Suppl. 1):1993;S19-S28.
9. Hack C.E., Ogilvie A.C., Eisele B.et al. Initial studies on the administration of C1-esterase inhibitor to patients with septic shock or with a vascular leak syndrome induced by interleukin-2 therapy. Prog. Clin. Biol. Res. 388:1994;335-357.
10. Haeney M.R. The role of the complement cascade in sepsis. J. Antimicrob. Chemother. 41(Suppl. A):1998;41-46.
11. Hattori R., Hamilton K.K., McEver R.P.et al. Complement proteins C5b-9 induce secretion of high molecular weight multimers of endothelial von Willebrand factor and translocation of granule membrane protein GMP-140 to the cell surface. J. Biol. Chem. 264(15):1989;9053-9060.
12. Issekutz A.C., Rowter D., Springer T.A. Role of ICAM-1 and ICAM-2 and alternate CD11/CD18 ligands in neutrophil transendothelial migration. J. Leukocyte Biol. 65(1):1999;117-126.
13. Keck T., Banafsche R., Werner J.et al. Desmopressin impairs microcirculation in donor pancreas and early graft function after experimental pancreas transplantation. Transplantation. 72(2):2001;202-209.
14. Kildsgaard J., Zsigmond E., Chan I.et al. A critical evaluation of the putative role of C3adesArg (ASP) in lipid metabolism and hyper- apobetalipoproteinemia. Mol. Immunol. 36(13-14):1999;869-876.
15. Kirschfink M. Controlling the complement system in inflammation. Immunopharmacology. 38(1-2):1997;51-62.
16. Kirschfink M., Mollnes T.E. C1-inhibitor: an anti-inflammatory reagent with therapeutic potential. Expert Opin. Pharmacother. 2(7):2001;1073-1083.
17. Koo D.J., Chaudry I.H., Wang P. Kupffer cells are responsible for producing inflammatory cytokines and hepatocellular dysfunction during early sepsis. J. Surg. Res. 83(2):1999;151-157.
18. Kumar A.G., Dai X.Y., Kozak C.A.et al. VCAM-1. Molecular cloning, mapping, and analysis of a truncated form. J. Immunol. 153(9):1994;4088-4098.
19. Larsen R. SIRS-Systemic Inflammatory Response Syndrome. Anasthesiol. Intensivmed. Notf.med. Schmerzther. 29(1):1994;36-37.
20. Lehmann T.G., Heger M., Munch S.et al. In vivo microscopy reveals that complement inhibition by C1-esterase inhibitor reduces ischemia/reperfusion injury in the liver. Transpl. Int. 13(Suppl. 1):2000;547-550.
21. Lehr H.A., Vollmar B., Vajkoczy P.et al. Intravital fluorescence microscopy for the study of leukocyte interaction with platelets and endothelial cells Leukocyte stasis in hepatic sinusoids. Methods Enzymol. 300(5 Pt. 1):1999;462-481.
22. Ley K. Molecular mechanisms of leukocyte recruitment in the inflammatory process. Cardiovasc. Res. 32(4):1996;733-742.
23. Ley K., Bullard D.C., Arbones M.L.et al. Sequential contribution of L- and P-selectin to leukocyte rolling in vivo. J. Exp. Med. 181(2):1995;669-675.
24. Lubbe A.S., Garrison R.N., Harris P.D. Endothelium-dependent microvascular responses to activated complement. J. Surg. Res. 57(6):1994;654-660.
25. Lubbe A.S., Garrison R.N., Harris P.D. Microcirculatory responses to complement activation are blunted by hypertension. J. Invest. Surg. 7(2):1994;73-84.
26. Masinovsky B., Urdal D., Gallatin W.M. IL-4 acts synergistically with IL-1 beta to promote lymphocyte adhesion to microvascular endothelium by induction of vascular cell adhesion molecule-1. J. Immunol. 145(9):1990;2886- 2895.
27. Mulligan M.S., Smith C.W., Anderson D.C.et al. Role of leukocyte adhesion molecules in complement-induced lung injury. J. Immunol. 150(6):1993;2401-2406.
28. Mulligan M.S., Wilson G.P., Todd R.F.et al. Role of beta 1, beta 2 integrins and ICAM-1 in lung injury after deposition of IgG and IgA immune complexes. J. Immunol. 150(6):1993;2407-2417.
29. Nakae H., Endo S., Inada K.et al. Chronological changes in the complement system in sepsis. Surg. Today. 26(4):1996;225-229.
30. Nath J., Kausalya S. Neutrophil-endothelial cell interactions. Inverse correlation between nitric oxide and superoxide anions. Ann. N. Y. Acad. Sci. 899:2000;411-414.
31. Nystrom P.O. The systemic inflammatory response syndrome: definitions and aetiology. J. Antimicrob. Chemother. 41(Suppl. A):1998;1-7.
32. Osborn L., Hession C., Tizard R.et al. Direct expression cloning of vascular cell adhesion molecule 1, a cytokine-induced endothelial protein that binds to lymphocytes. Cell. 59(6):1989;1203-1211.
33. Pober J.S., Gimbrone M.A., Lapierre L.A.et al. Overlapping patterns of activation of human endothelial cells by interleukin 1, tumor necrosis factor, and immune interferon. J. Immunol. 137(6):1986;1893-1896.
34. Ring A., Stremmel W. The hepatic microvascular responses to sepsis. Semin. Thromb. Hemostasis. 26(5):2000;589-594.
35. Sauer A., Hartung T., Aigner J.et al. Endotoxin-inducible granulocyte-mediated hepatocytotoxicity requires adhesion and serine protease release. J. Leukocyte Biol. 60(5):1996;633-643.
36. Schmidt W., Stenzel K., Gebhard M.M.et al. C1-esterase inhibitor and its effects on endotoxin-induced leukocyte adherence and plasma extravasation in postcapillary venules. Surgery. 125(3):1999;280-287.
37. Schuder G.B., Vollmar S., Richter G.et al. Epi-illumination fluorescent light microscopy for the in vivo study of rat hepatic microvascular response to cryothermia. Hepatology. 29(3):1999;801-808.
38. Secchi A., Ortanderl J.M., Schmidt W.et al. Effect of endotoxemia on hepatic portal and sinusoidal blood flow in rats. J. Surg. Res. 89(1):2000;26-30.
39. Sheth K., Bankey P. The liver as an immune organ. Curr. Opin. Crit. Care. 7(2):2001;99-104.
40. Sheth K.A., Duffy B., Nolan B.et al. Activated neutrophils induce nitric oxide production in Kupffer cells. Shock. 14(3):2000;380-384.
41. Sim R.B., Reboul A., Arlaud G.J.et al. Interaction of 125I-labelled complement subcomponents C-1r and C-1s with protease inhibitors in plasma. FEBS Lett. 97(1):1979;111-115.
42. Singer M. Management of multiple organ failure: guidelines but no hard-and-fast rules. J. Antimicrob. Chemother. 41(Suppl. A):1998;103-112.
43. Smets D., Spapen H., Diltoer M.et al. Liver perfusion and hepatocellular inflammatory response in sepsis. Acta Clin. Belg. 54(4):1999;201-206.
44. Steeber D.A., Tang M.L., Green N.E.et al. Leukocyte entry into sites of inflammation requires overlapping interactions between the L-selectin and ICAM-1 pathways. J. Immunol. 163(4):1999;2176-2186.
45. Tozeren A., Ley K. How do selectins mediate leukocyte rolling in venules? Biophys. J. 63(3):1992;700-709.
46. van Oosten M.E., van de Bilt H.E., de Vries T.J.et al. Vascular adhesion molecule-1 and intercellular adhesion molecule-1 expression on rat liver cells after lipopolysaccharide administration in vivo. Hepatology. 22(5):1995;1538-1546.
47. Vollmar B., Menger M.D. The use of intravital microscopy in surgical research. 26-years of experience analyzed by studies presented at the Surgical Forum of the Annual Congress of the German Society of Surgery. Langenbecks Arch. Surg. 383(3-4):1998;282-285.
48. Vollmar B., Glasz J., Senkel A.et al. Role of leukocytes in the initial hepatic microvascular response to endotoxemia. Zentralbl. Chir. 118(11):1993;691-696.
49. Vollmar B., Senkel A., Menger M.D. In vivo evidence that intercellular adhesion molecule-1 does not mediate endotoxin-induced hepatic leukocyte-endothelial cell interaction. J. Hepatol. 23(5):1995;613-616.
50. Vollmar B., Richter S., Menger M.D. Leukocyte stasis in hepatic sinusoids. Am. J. Physiol. 270(5 Pt. 1):1996;G798-G803.
51. Wang P., Chaudry I.H. Mechanism of hepatocellular dysfunction during hyperdynamic sepsis. Am. J. Physiol. 270(5 Pt. 2):1996;R927-R938.
52. Wang P., Ayala A., Ba Z.F.et al. Tumor necrosis factor-alpha produces hepatocellular dysfunction despite normal cardiac output and hepatic microcirculation. Am. J. Physiol. 265(1 Pt. 1):1993;G126-G132.
53. Wang P., Ba Z.F., Chaudry I.C.H. Mechanism of hepatocellular dysfunction during early sepsis. Key role of increased gene expression and release of proinflammatory cytokines tumor necrosis factor and interleukin-6. Arch. Surg. 132(4):1997;364-369.
54. Wang H.H., Nance D.M., Orr F.W. Murine hepatic microvascular adhesion molecule expression is inducible and has a zonal distribution. Clin. Exp. Metastasis. 17(2):1999;149-155.
55. Williams A.J., Atkins R.C., Fries J.W.et al. Nucleotide sequence of rat vascular cell adhesion molecule-1 cDNA. Biochim. Biophys. Acta. 1131(2):1992;214-216.
56. Willam C., Schindler R., Frei U.et al. Increases in oxygen tension stimulate expression of ICAM-1 and VCAM-1 on human endothelial cells. Am. J. Physiol. 276(6 Pt. 2):1999;H2044-H2052.
57. Wurster S.H., Wang P., Dean R.E.et al. Vascular smooth muscle contractile function is impaired during early and late stages of sepsis. J. Surg. Res. 56(6):1994;556-561.